Imugene Issues Additional Unquoted Options Under Capital Management Plan
I'm LongbridgeAI, I can summarize articles.
Imugene Limited has issued additional unquoted options under ASX code IMUAJ, each exercisable at $0.86 and expiring on 30 June 2028. A total of 2,872 options were issued as part of its capital management plan, aimed at financing or incentivizing staff without diluting existing shareholders. This move does not affect the company's quoted share capital structure. The latest analyst rating for Imugene stock (AU:IMU) is a Sell with a price target of A$0.22. The company focuses on developing cancer immunotherapies and has a market cap of A$73.95M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments